Related Experiment Video
Updated: Mar 9, 2026

Ischemia-reperfusion Model of Acute Kidney Injury and Post Injury Fibrosis in Mice
Published on: August 9, 2013
Incremental prognostic value of SPECT-MPI in chronic kidney disease: A reclassification analysis
Amjad M Ahmed1, Waqas T Qureshi2, Wesley T O'Neal2
1King Abdulaziz Cardiac Center, King Abdulaziz Medical City, Ministry of National Guard-Health Affairs, P.O. Box 22490, Riyadh, 11426, Saudi Arabia.
Insights
Single-photon emission computerized tomography-myocardial perfusion imaging (SPECT-MPI) detects perfusion defects that independently predict cardiovascular mortality in chronic kidney disease (CKD) patients. This imaging significantly improves risk stratification beyond traditional factors.
Area of Science:
- Cardiology
- Nephrology
- Nuclear Medicine
Background:
- Traditional cardiovascular (CV) risk factors have limited predictive value for CV mortality in patients with chronic kidney disease (CKD).
- CKD is defined as creatinine clearance less than 60 mL/minute per 1.73 m².
- There is a need for improved risk stratification in CKD patients.
Purpose of the Study:
- To evaluate the incremental and independent prognostic value of single-photon emission computerized tomography-myocardial perfusion imaging (SPECT-MPI).
- To assess SPECT-MPI's predictive capability across the continuum of renal function in CKD patients.
- To determine if SPECT-MPI improves risk prediction beyond traditional CV risk factors and GFR.
Main Methods:
- Retrospective study of 11,518 patients undergoing SPECT-MPI.
- Primary endpoint: composite of cardiac death and non-fatal myocardial infarction (CD/MI).
- Analysis of total perfusion defect (TPD) using Cox regression, adjusting for CV risk factors and GFR, and assessing incremental predictive value with Harrell's c-index, NRI, and IDI.
Main Results:
- Over a median 5-year follow-up, 14.5% of patients experienced CD/MI.
- Perfusion defects on SPECT-MPI were independently associated with increased CD/MI risk (HR=2.10, p<.001), even after adjusting for CV risk factors and GFR.
- TPD significantly improved discriminatory ability (AUC increased from 0.725 to 0.784, p<.0001) and risk stratification (NRI=14%, relative IDI=60%, p<.001) compared to traditional factors.
Conclusions:
- SPECT-MPI-detected perfusion defects independently and incrementally predict CD/MI risk in patients across the spectrum of renal function.
- SPECT-MPI offers significant prognostic value beyond traditional CV risk factors and GFR in CKD patients.
- These findings support the use of SPECT-MPI for enhanced risk stratification in CKD.
Background:
Traditional cardiovascular (CV) risk factors have limited predictive value of CV mortality in patients with chronic kidney disease (CKD, creatinine clearance less than 60 mL/minute per 1.73 m2). The aim of this study was to evaluate incremental and independent prognostic value of single-photon emission computerized tomography-myocardial perfusion imaging (SPECT-MPI) across continuum of renal function.
Methods:
We retrospectively studied 11,518 (mean age, 65 ± 12 years; 52% were men) patients referred for a clinical indication of SPECT-MPI between April 2004 and May 2009. Primary end point was composite of cardiac death and non-fatal myocardial infarction (CD/MI). We examined the relationship of total perfusion defect (TPD) and CD/MI in multiple Cox regression models for CV risk factors and GFR. The incremental predictive value of TPD was examined using Harrell's c-index, net reclassification index (NRI), and integrated discrimination index (IDI).
Results:
Over a median follow-up of 5 years (25th to 75th percentiles, 3.0-6.5 years), 1,692 (14.5%) patients experienced CD/MI (740 MI and 1,182 CD). In a multivariable model adjusted for traditional CV risk factors and GFR, the presence of a perfusion defect was independently associated with increased risk of CD/MI (HR = 2.10; 95% CI 1.81, 2.43, p < .001). Using Cox regression, TPD improved the discriminatory ability beyond traditional CV risk factors and GFR [from AUC = 0.725, (95% CI 0.712-0.738) to 0.784, (95% CI 0.772-0.796), p < .0001]. Furthermore, TPD improves risk stratification of CKD patients over and above traditional CV risk factors and GFR [NRI = 14%, 95% CI (12%-16%, p < .001) and relative IDI = 60%, 95% CI (51%, 66%, p < .001)].
Conclusions:
Across the spectrum of renal function, SPECT-MPI perfusion defects independently and incrementally reclassified patients for their risk of CD/MI, beyond traditional CV risk factors.
More Related Videos
07:35Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
Published on: June 23, 2015
07:01A Quantitative Detection Method for MicroRNAs in the Kidney of an Ischemic Kidney Injury Mouse Model
Published on: September 11, 2020
Related Concept Videos
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury III: Clinical Manifestations
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease I: Introduction